Axcelis Unveils Purion H6: Next-Generation High Current Ion Implanter for Advanced Semiconductor Manufacturing

Axcelis (NASDAQ: ACLS) on Feb. 4, 2026 unveiled the Purion H6, a next‑generation high current ion implanter built for advanced semiconductor manufacturing.

Rhea-AI Summary

Axcelis (NASDAQ: ACLS) on Feb. 4, 2026 unveiled the Purion H6, a next‑generation high current ion implanter built for advanced semiconductor manufacturing. The system emphasizes dose control, enhanced particle control, Eterna ELS7 source technology, higher beam currents and improved throughput, reliability and lower cost of ownership.

The Purion H6 targets logic, advanced memory, image sensor and mature technology segments and will be exhibited at SEMICON Korea, Feb. 11–13, booth #D522.

Argus Feb 4 session

-1.91% close to close Open Argus

Details

News Market Reaction – ACLS

On Feb 4, the day this news came out, ACLS closed 1.91% below the previous close.

Data tracked by StockTitan Argus for the Feb 4 session.

Key Figures

Q3 2025 revenue: $213.6M Prior-year Q3 revenue: $256.6M Q3 2025 net income: $26.0M +5 more

Q3 2025 revenue

$213.6M

Quarter ended Sep 30, 2025; down from $256.6M prior year

Prior-year Q3 revenue

$256.6M

Quarter ended Sep 30, 2024 comparison

Q3 2025 net income

$26.0M

Quarter ended Sep 30, 2025; vs $48.6M prior year

Q3 2025 diluted EPS

$0.83

Quarter ended Sep 30, 2025; vs $1.49 prior year

9M 2025 revenue

$600.7M

First nine months 2025; vs $765.4M prior year

Cash & equivalents

$187.5M

As of Q3 2025 balance sheet

Shares repurchased YTD

1.5M shares at $62.33

Year‑to‑date through Q3 2025 under repurchase program

Veeco exchange ratio

0.3575 ACLS/share

All‑stock merger: Axcelis shares per Veeco share

Historical Context

5 past events · Latest: Jan 26

5 events

1. Jan 26

   Earnings call timing

   24h Move

   -2.1%

   Announced release date and conference call for Q4 and full‑year 2025 results.

2. Jan 15

   Manufacturing commitment

   24h Move

   +3.5%

   Regional leaders praised Whirlpool’s long‑term U.S. manufacturing and investment plans.

3. Jan 08

   Investor conference

   24h Move

   -3.3%

   Announced participation and investor meetings at the 28th Annual Needham Growth Conference.

4. Dec 10

   Trade show showcase

   24h Move

   +1.6%

   Planned exhibit of advanced ion implant systems at SEMICON Japan 2025.

5. Nov 06

   Investor conferences

   24h Move

   -2.7%

   Outlined participation in Wells Fargo TMT Summit and NYC Summit investor events.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

ion implanter, dosimetry, beamline

3 terms

ion implanter technical

"introduced the Purion H6™ high current ion implanter—engineered to meet the demands"

An ion implanter is a machine used in making computer chips that shoots tiny charged atoms into a silicon wafer to change how parts of the chip conduct electricity, much like seasoning a dish to change its flavor. Investors care because it is essential capital equipment for chip factories — affecting production capacity, manufacturing costs and the performance of the finished chips — so sales or shortages can signal shifts in supply, pricing and company competitiveness.

dosimetry technical

"beamline with innovations in source life, particle control, and dosimetry."

Dosimetry is the measurement and calculation of how much ionizing radiation is absorbed by people, tissues, or devices, similar to a thermostat tracking temperature in different rooms to know where and how much heat is present. Investors should care because accurate dosimetry underpins safety, treatment effectiveness, regulatory approval, and liability for products and services that use radiation—affecting market access, costs, and commercial risk.

beamline technical

"This next generation system combines a high throughput beamline with innovations"

A beamline is a controlled path inside a research facility that directs focused beams of particles or very bright X-ray or light energy from a source to an experiment. Think of it as a specialized highway that delivers precise, high-energy tools scientists use to image materials, probe biological molecules, or test new drugs; its availability and performance can accelerate discoveries, attract collaborators and funding, and therefore influence the commercial prospects of companies tied to those breakthroughs.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BEVERLY, Mass., Feb. 4, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, today introduced the Purion H6™ high current ion implanter—engineered to meet the demands of next-generation semiconductor devices with unmatched purity, precision and productivity.

The Purion H6 builds on the success of the well-established Purion H product line, integrating new technologies to support today's most advanced device manufacturing. This next generation system combines a high throughput beamline with innovations in source life, particle control, and dosimetry. These enhancements deliver the highest quality beam while driving ease of use, low cost of ownership, and overall system reliability. The Purion H6 provides customers with a single solution designed specifically to meet these challenges across the full spectrum of existing and emerging high current applications in logic, advanced memory, image sensor and mature technology market segments.

Purion H6 High Current Implanter Advantages:

• Next Generation Dose Control – Provides superior repeatability, wafer safety and cost of operation. 
• Enhanced Particle Control – Optimized beam line design reduces contamination, improving yield while reducing preventative maintenance frequency and cost.
• Eterna™ ELS7 Source Technology – Delivers improved beam stability and repeatability, reduced preventative maintenance time and complexity, and extended source life. 
• Best in Class Productivity – Delivers the highest beam currents in its class, enabling industry leading throughput.

President and CEO, Dr. Russell Low, commented, "We're excited to launch the new Purion H6 next generation high current ion implanter, designed to support our customers' most advanced semiconductor device manufacturing challenges. Axcelis is focused on innovative implant solutions that drive the process performance and Cost of Ownership required to enable major device inflections in logic, advanced memory, image sensor and mature technology market segments.

Executive Vice President, Dr. Greg Redinbo, noted, "Designed in close collaboration with our customers, we've created a platform that sets new benchmarks in implant purity, precision and productivity. The new system introduces an innovative new dose control technology and enhanced beamline optimization — achieving exceptional implant process control while delivering best-in-class productivity, and capital efficiency."

More information on the Purion H6, including a product video, can be found on the Axcelis website.

The new system, along with other ion implant innovations for making next generation semiconductor devices, will be on display at the Axcelis booth #D522 at SEMICON Korea, at COEX in Seoul, South Korea from Feb. 11-13.

About Axcelis:
Axcelis (Nasdaq: ACLS), headquartered in Beverly, Mass., has been providing innovative, high-productivity solutions for the semiconductor industry for over 45 years. Axcelis is dedicated to developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation systems, one of the most critical and enabling steps in the IC manufacturing process. Learn more about Axcelis at www.axcelis.com.

Safe Harbor Statement
Statements made in this press release that are not of known historical fact are forward-looking statements and are subject to the safe harbor provisions created by the Private Securities Litigation Reform Act of 1995. These statements, which include statements regarding our products, are based on management's current expectations and should be viewed with caution. They are subject to various risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, including the risks and uncertainties that are described in the documents filed or furnished by us with the Securities and Exchange Commission, including specifically the risk factors described in our Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q. The Company undertakes no obligation to update the information or statements made in this press release.

CONTACTS:

Press/Media Relations Contact: 
Maureen Hart
Senior Director, Corporate & Marketing Communications
Telephone: (978) 787-4266
Email: Maureen.Hart@axcelis.com

Investor Relations Contact:
David Ryzhik
Senior Vice President, Investor Relations and Corporate Strategy
Telephone: (978) 787-2352
Email: David.Ryzhik@axcelis.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/axcelis-unveils-purion-h6-next-generation-high-current-ion-implanter-for-advanced-semiconductor-manufacturing-302678762.html

SOURCE Axcelis Technologies, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is the Purion H6 ion implanter announced by Axcelis (ACLS) on Feb. 4, 2026?

The Purion H6 is a next‑generation high current ion implanter designed for advanced device manufacturing. According to the company, it combines improved dose control, particle control and Eterna ELS7 source technology to boost throughput, reliability and lower cost of ownership.

How does Purion H6 improve dose control and wafer safety for ACLS customers?

Purion H6 offers next‑generation dose control that enhances repeatability and wafer safety during implant processes. According to the company, the new dose control reduces variability and aims to lower operating costs and rework for advanced manufacturing nodes.

What productivity gains does Axcelis claim for the Purion H6 (ACLS)?

Axcelis says the Purion H6 delivers the highest beam currents in its class for industry‑leading throughput. According to the company, the design enables faster processing speeds and improved capital efficiency for high current applications across multiple device segments.

What is Eterna ELS7 source technology in the Purion H6 and why does ACLS highlight it?

Eterna ELS7 is the Purion H6 source tech that improves beam stability and extends source life. According to the company, it reduces preventative maintenance time and complexity while improving repeatability for production fabs.

When and where will Axcelis (ACLS) showcase the Purion H6 to customers and attendees?

Axcelis will display the Purion H6 at SEMICON Korea, Feb. 11–13, 2026, at COEX in Seoul, booth #D522. According to the company, the exhibit will include the new system and related ion implant innovations and a product video online.